Robinson, M J <br/><br/>
Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.  [electronic resource] 

 -  Biochemistry  Apr 1993 
 - 3638-43 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-2960 
<br/><br/><label>Standard No.: </label>10.1021/bi00065a016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--metabolism<br/>Amsacrine--pharmacology<br/>Animals<br/>Anti-Infective Agents<br/>Antineoplastic Agents--pharmacology<br/>Binding Sites<br/>Cell Nucleus--enzymology<br/>DNA Topoisomerases, Type II--chemistry<br/>DNA, Bacterial--metabolism<br/>Drosophila melanogaster--enzymology<br/>Escherichia coli--genetics<br/>Etoposide--pharmacology<br/>Fluoroquinolones<br/>Genistein<br/>Hydrolysis<br/>Isoflavones--pharmacology<br/>Novobiocin--pharmacology<br/>Plasmids<br/>Quercetin--analogs & derivatives<br/>Quinolones--pharmacology<br/>Topoisomerase II Inhibitors